Light Mode
$22.68 ↑ +0.00 (+0.00%) Trading Up from the previous close of $22.68, $0.05 below the day’s high of $22.73
-0.09 (-0.40%) / 6M
Momentum, market sentiment, and recent alerts
FMS reads very good: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is -16.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.